Psychopharmacology and Psychiatry Updates
By Psychopharmacology Institute
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Psychopharmacology Institute
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 124
Reviews: 0
Episodes: 100
Description
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
| Episode | Date |
|---|---|
|
Motherhood and Medication: LAIs for Women with Schizophrenia
|
May 21, 2025 |
|
Benzodiazepines in High-Risk Populations
|
May 16, 2025 |
|
Benzodiazepines: Understanding Physical Dependence vs. Addiction
|
May 11, 2025 |
|
Beyond Metformin: Probiotics and Antipsychotic Weight Gain
|
May 06, 2025 |
|
What Every Clinician Should Know About the Risks of Benzodiazepines
|
May 01, 2025 |
|
Making an Exit Plan: Navigating Antidepressant Discontinuation
|
Apr 26, 2025 |
|
Clinical Pearls for Selecting the Right Benzodiazepine
|
Apr 21, 2025 |
|
TMS for Depression: From Clinical Trials to Results
|
Apr 16, 2025 |
|
A Guide to Selecting TMS Candidates
|
Apr 11, 2025 |
|
Rethinking Clozapine Monitoring: 22 Years of Data
|
Apr 06, 2025 |
|
Understanding TMS in OCD: Evidence and Practice
|
Apr 01, 2025 |
|
Breaking Down the TRAILBLAZER-ALZ 2 Trial
|
Mar 27, 2025 |
|
Long-term Benzo Use: What The Data Really Show
|
Mar 22, 2025 |
|
Navigating TMS Side Effects: A Practical Guide
|
Mar 17, 2025 |
|
SSRIs and Anticoagulants: Navigating Bleeding Risk
|
Mar 12, 2025 |
|
Lamotrigine and the Heart: What You Need to Know
|
Mar 07, 2025 |
|
After the Last Dose: Understanding Antipsychotic Discontinuation
|
Mar 02, 2025 |
|
Understanding Lamotrigine's Cardiac Effects
|
Feb 25, 2025 |
|
Rethinking Falls: Are Sleep Medications Really to Blame?
|
Feb 20, 2025 |
|
Navigating Lamotrigine's Side Effects
|
Feb 15, 2025 |
|
Iloperidone in Bipolar Disorder: A New Treatment Option?
|
Feb 10, 2025 |
|
Lamotrigine: Pearls for Prescribing
|
Feb 05, 2025 |
|
Beyond Benzos: New Frontiers in Agitation Management
|
Jan 31, 2025 |
|
KarXT: A New Dawn in Antipsychotic Treatment
|
Jan 26, 2025 |
|
Rethinking Agitation Management: From Force to Partnership
|
Jan 21, 2025 |
|
COVID Brain Fog: Repurposing Famotidine
|
Jan 16, 2025 |
|
Beyond Restraints: De-Escalation in Behavioral Emergencies
|
Jan 11, 2025 |
|
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
|
Jan 06, 2025 |
|
Unraveling Agitation: Mania vs. Substance Use
|
Jan 01, 2025 |
|
Pushing the Boundaries: Exploring High-Dose Antipsychotics
|
Dec 27, 2024 |
|
The Psychodynamic Prescriber
|
Dec 22, 2024 |
|
From Inpatient to Outpatient: Initiating Benzodiazepine Tapering
|
Dec 17, 2024 |
|
The Power of Alliance in Psychopharmacology
|
Dec 12, 2024 |
|
Antipsychotics in Youth: Balancing Metabolic Risk
|
Dec 07, 2024 |
|
The Double-Edged Sword of Biological Explanations in Mental Health
|
Dec 02, 2024 |
|
New Insights into Psychiatric and Cardiovascular Comorbidity
|
Nov 27, 2024 |
|
Beyond the Pill: The Psychology of Psychopharmacology
|
Nov 22, 2024 |
|
On Methylphenidate and Sleep: A Two-Year Study
|
Nov 17, 2024 |
|
Nature's Pharmacy: Combining Natural Remedies in Psychiatry
|
Nov 12, 2024 |
|
Breaking the Cycle: Memantine in Body-Focused Repetitive Behaviors
|
Nov 07, 2024 |
|
The Potential of Ashwagandha in Psychiatry
|
Nov 02, 2024 |
|
Treatment Dilemmas: ECT for Depressed Teens
|
Oct 28, 2024 |
|
CBD in Psychiatry: Promise or Hype?
|
Oct 23, 2024 |
|
Beyond Dopamine: Cannabidiol in Parkinson's Care
|
Oct 18, 2024 |
|
Is NAC Promising in Bipolar and Depression Treatment?
|
Oct 13, 2024 |
|
Microbes and the Mind: Probiotics and ADHD
|
Oct 08, 2024 |
|
Lithium, Lamotrigine, and Labor: Managing Bipolar Disorder in Expectant Mothers
|
Oct 03, 2024 |
|
Rethinking Haloperidol in Geriatric Delirium
|
Sep 28, 2024 |
|
Antipsychotics in Pregnancy: A Balancing Act
|
Sep 23, 2024 |
|
Risperidone in Youth Anorexia: A Promising Solution?
|
Sep 18, 2024 |
|
Navigating Lithium: A Guide for Expectant Mothers with Bipolar Disorder
|
Sep 13, 2024 |
|
DORA: A New Frontier in Insomnia Treatment
|
Sep 08, 2024 |
|
Debunking Myths: Lithium Use in Pregnancy
|
Sep 03, 2024 |
|
SSRIs and Kids: Escitalopram for Pediatric Anxiety
|
Aug 29, 2024 |
|
Unraveling Treatment Resistance: A Psychodynamic Approach
|
Aug 24, 2024 |
|
Psychedelics: A New Frontier in Psychiatry
|
Aug 19, 2024 |
|
Beyond the Prescription Pad: Navigating Patient Ambivalence
|
Aug 14, 2024 |
|
Unplugging from Vaping: Cessation Strategies for Teens
|
Aug 09, 2024 |
|
When Drugs Don't Work: A Psychodynamic Approach
|
Aug 04, 2024 |
|
Rethinking Rx: Benzodiazepines and Suicide Risk
|
Jul 30, 2024 |
|
The Psychology of Prescribing: Optimizing Outcomes Through Understanding
|
Jul 25, 2024 |
|
ADHD and Pain: A Surprising Link
|
Jul 20, 2024 |
|
Restoring Rest: Insomnia Interventions for Depressed Patients
|
Jul 15, 2024 |
|
Restoring Sleep in Major Depression: Orexin, Melatonin, and More
|
Jul 10, 2024 |
|
Enhancing Pediatric Depression Treatment: The Role of Fish Oil and CBT
|
Jul 05, 2024 |
|
Pharmacological Strategies for Insomnia in MDD
|
Jun 30, 2024 |
|
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
|
Jun 25, 2024 |
|
Insomnia and Depression: A Tangled Web
|
Jun 20, 2024 |
|
ADHD Treatment During Pregnancy: Insights from Denmark
|
Jun 15, 2024 |
|
The Power of Nonpharmacologic Therapies in Fibromyalgia
|
Jun 10, 2024 |
|
Highlights From APA 2024: Key Insights on Psychopharmacology
|
Jun 05, 2024 |
|
Antidepressants in Pregnancy: Weighing the Evidence
|
May 31, 2024 |
|
Unraveling the Pharmacological Puzzle of Fibromyalgia
|
May 26, 2024 |
|
Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa
|
May 21, 2024 |
|
Beyond the Pain: Diagnosing Fibromyalgia
|
May 17, 2024 |
|
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
|
May 11, 2024 |
|
Mastering Clozapine: Adverse Effect Management
|
May 06, 2024 |
|
Preventing Depression and Anxiety Relapse in Youth
|
May 01, 2024 |
|
Charting the Clozapine Course: Titration and Monitoring
|
Apr 26, 2024 |
|
Smoking and Psychosis: Insights from the PATH Study
|
Apr 21, 2024 |
|
Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
|
Apr 16, 2024 |
|
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
|
Apr 11, 2024 |
|
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
|
Apr 06, 2024 |
|
Zuranolone: A New Dawn for Postpartum Depression Treatment
|
Apr 01, 2024 |
|
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
|
Mar 27, 2024 |
|
Olanzapine in Pregnancy: Examining the Risks
|
Mar 22, 2024 |
|
Understanding Safety Risks of Broad-Spectrum Micronutrients
|
Mar 17, 2024 |
|
The Role of Inflammation in Delirium: Can NSAIDs Help?
|
Mar 12, 2024 |
|
Beyond Medication: Exploring Nutritional Psychiatry
|
Mar 07, 2024 |
|
Age Impact on Antidepressant Outcomes
|
Mar 02, 2024 |
|
Dealing With Delirium in Patients With Advanced Cancer
|
Feb 26, 2024 |
|
Rechallenging Clozapine: A Look at Colony Stimulating Factors
|
Feb 21, 2024 |
|
Managing Anxiety in Patients With Cancer
|
Feb 16, 2024 |
|
Managing Antidepressant Side Effects in Youth
|
Feb 11, 2024 |
|
Depressed Patient With Cancer? Here’s How to Treat
|
Feb 06, 2024 |
|
Brexanolone: A Quick Fix for Postpartum Depression and Anxiety?
|
Feb 01, 2024 |
|
The Nitty-Gritty on Treatment Optimization for Tic Disorders in Youth
|
Jan 27, 2024 |
|
Untangling Dilemmas: Youth Cannabis-ADHD-Stimulant Med Misuse
|
Jan 22, 2024 |
|
Tic Disorders and Psychiatric Comorbidities in Youth: Treatment Cheat Sheet
|
Jan 17, 2024 |
|
Clinician’s Digest: CANMAT and Mixed States Practicalities
|
Jan 12, 2024 |